U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Anaplastic Astrocytoma

MedGen UID:
1621925
•Concept ID:
C4522224
•
Neoplastic Process

Definition

The reemergence of anaplastic astrocytoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Anaplastic Astrocytoma

Professional guidelines

PubMed

Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
Korones DN, Smith A, Foreman N, Bouffet E
Pediatr Blood Cancer 2006 Jul;47(1):37-41. doi: 10.1002/pbc.20510. PMID: 16047359
Pilot study of estramustine added to radiosurgery and radiotherapy for treatment of high grade glioma.
Landy H, Markoe A, Potter P, Lasalle G, Marini A, Savaraj N, Reis I, Heros D, Wangpaichitr M, Feun L
J Neurooncol 2004 Mar-Apr;67(1-2):215-20. doi: 10.1023/b:neon.0000021825.41221.b5. PMID: 15072470
Interstitial radiogold implantation for the treatment of recurrent high-grade gliomas.
Larson GL, Wilbanks JH, Dennis WS, Permenter WD, Easley JD
Cancer 1990 Jul 1;66(1):27-9. doi: 10.1002/1097-0142(19900701)66:1<27::aid-cncr2820660106>3.0.co;2-w. PMID: 2162243

Recent clinical studies

Etiology

Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [(18)F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma.
Henriksen OM, Hansen AE, Muhic A, Marner L, Madsen K, Møller S, Hasselbalch B, Lundemann MJ, Scheie D, Skjøth-Rasmussen J, Poulsen HS, Larsen VA, Larsson HBW, Law I
Eur J Nucl Med Mol Imaging 2022 Nov;49(13):4677-4691. Epub 2022 Jul 30 doi: 10.1007/s00259-022-05917-3. PMID: 35907033Free PMC Article
Salvage therapy with lomustine for temozolomide refractory recurrent anaplastic astrocytoma: a retrospective study.
Chamberlain MC
J Neurooncol 2015 Apr;122(2):329-38. Epub 2015 Jan 7 doi: 10.1007/s11060-014-1714-9. PMID: 25563816
MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma.
Sadones J, Michotte A, Veld P, Chaskis C, Sciot R, Menten J, Joossens EJ, Strauven T, D'Hondt LA, Sartenaer D, Califice SF, Bierau K, Svensson C, De Grève J, Neyns B
Eur J Cancer 2009 Jan;45(1):146-53. Epub 2008 Oct 20 doi: 10.1016/j.ejca.2008.09.002. PMID: 18945611
Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytoma.
Chamberlain MC, Tsao-Wei DD, Groshen S
Cancer 2006 Jan 1;106(1):172-9. doi: 10.1002/cncr.21582. PMID: 16323194
Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
Korones DN, Smith A, Foreman N, Bouffet E
Pediatr Blood Cancer 2006 Jul;47(1):37-41. doi: 10.1002/pbc.20510. PMID: 16047359

Diagnosis

Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [(18)F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma.
Henriksen OM, Hansen AE, Muhic A, Marner L, Madsen K, Møller S, Hasselbalch B, Lundemann MJ, Scheie D, Skjøth-Rasmussen J, Poulsen HS, Larsen VA, Larsson HBW, Law I
Eur J Nucl Med Mol Imaging 2022 Nov;49(13):4677-4691. Epub 2022 Jul 30 doi: 10.1007/s00259-022-05917-3. PMID: 35907033Free PMC Article
Extracranial bone metastases from recurrent anaplastic astrocytoma on FDG PET/CT: A case report a care-compliant article.
Li ZG, Mu HY
Medicine (Baltimore) 2017 Jun;96(23):e7123. doi: 10.1097/MD.0000000000007123. PMID: 28591062Free PMC Article
Temozolomide: a milestone in neuro-oncology and beyond?
Mutter N, Stupp R
Expert Rev Anticancer Ther 2006 Aug;6(8):1187-204. doi: 10.1586/14737140.6.8.1187. PMID: 16925485
Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
Korones DN, Smith A, Foreman N, Bouffet E
Pediatr Blood Cancer 2006 Jul;47(1):37-41. doi: 10.1002/pbc.20510. PMID: 16047359
Temozolomide: a milestone in the pharmacotherapy of brain tumors.
Weller M, Steinbach JP, Wick W
Future Oncol 2005 Dec;1(6):747-54. doi: 10.2217/14796694.1.6.747. PMID: 16556052

Therapy

Salvage therapy with lomustine for temozolomide refractory recurrent anaplastic astrocytoma: a retrospective study.
Chamberlain MC
J Neurooncol 2015 Apr;122(2):329-38. Epub 2015 Jan 7 doi: 10.1007/s11060-014-1714-9. PMID: 25563816
Temozolomide: a milestone in neuro-oncology and beyond?
Mutter N, Stupp R
Expert Rev Anticancer Ther 2006 Aug;6(8):1187-204. doi: 10.1586/14737140.6.8.1187. PMID: 16925485
Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
Korones DN, Smith A, Foreman N, Bouffet E
Pediatr Blood Cancer 2006 Jul;47(1):37-41. doi: 10.1002/pbc.20510. PMID: 16047359
Temozolomide: a milestone in the pharmacotherapy of brain tumors.
Weller M, Steinbach JP, Wick W
Future Oncol 2005 Dec;1(6):747-54. doi: 10.2217/14796694.1.6.747. PMID: 16556052
Stereotaxic irradiation of brain tumors.
Larson DA, Gutin PH, Leibel SA, Phillips TL, Sneed PK, Wara WM
Cancer 1990 Feb 1;65(3 Suppl):792-9. doi: 10.1002/1097-0142(19900201)65:3+<792::aid-cncr2820651327>3.0.co;2-p. PMID: 2154318

Prognosis

5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
Chohan MO, Berger MS
J Neurooncol 2019 Feb;141(3):517-522. Epub 2018 Aug 10 doi: 10.1007/s11060-018-2956-8. PMID: 30097823
Temozolomide: a milestone in neuro-oncology and beyond?
Mutter N, Stupp R
Expert Rev Anticancer Ther 2006 Aug;6(8):1187-204. doi: 10.1586/14737140.6.8.1187. PMID: 16925485
Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
Korones DN, Smith A, Foreman N, Bouffet E
Pediatr Blood Cancer 2006 Jul;47(1):37-41. doi: 10.1002/pbc.20510. PMID: 16047359
Temozolomide: a milestone in the pharmacotherapy of brain tumors.
Weller M, Steinbach JP, Wick W
Future Oncol 2005 Dec;1(6):747-54. doi: 10.2217/14796694.1.6.747. PMID: 16556052
A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme.
Aoki T, Mizutani T, Ishikawa M, Sugiyama K, Hashimoto N
Int J Clin Oncol 2003 Oct;8(5):301-4. doi: 10.1007/s10147-003-0339-3. PMID: 14586755

Clinical prediction guides

5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
Chohan MO, Berger MS
J Neurooncol 2019 Feb;141(3):517-522. Epub 2018 Aug 10 doi: 10.1007/s11060-018-2956-8. PMID: 30097823
Temozolomide: a milestone in neuro-oncology and beyond?
Mutter N, Stupp R
Expert Rev Anticancer Ther 2006 Aug;6(8):1187-204. doi: 10.1586/14737140.6.8.1187. PMID: 16925485
Temozolomide: a milestone in the pharmacotherapy of brain tumors.
Weller M, Steinbach JP, Wick W
Future Oncol 2005 Dec;1(6):747-54. doi: 10.2217/14796694.1.6.747. PMID: 16556052
A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme.
Aoki T, Mizutani T, Ishikawa M, Sugiyama K, Hashimoto N
Int J Clin Oncol 2003 Oct;8(5):301-4. doi: 10.1007/s10147-003-0339-3. PMID: 14586755
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials.
Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung WK
J Clin Oncol 1999 Aug;17(8):2572-8. doi: 10.1200/JCO.1999.17.8.2572. PMID: 10561324

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...